Skip to Content
Merck
CN

SML3866

Sigma-Aldrich

SCR2682

≥98% (HPLC)

Synonym(s):

N-[4-(2-Bromo-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide

Sign Into View Organizational & Contract Pricing

Select a Size


About This Item

Empirical Formula (Hill Notation):
C21H27BrN2OS
CAS Number:
Molecular Weight:
435.42
UNSPSC Code:
12352200
NACRES:
NA.21
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

Assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear (warmed)

storage temp.

room temp

Biochem/physiol Actions

Potent and selective opener of neuronal Kv7/KCNQ/M-channels that activates the native M-current in rat hippocampal or cortical neurons
SCR2682 is potent and selective opener of neuronal Kv7/KCNQ/M-channels that activates the native M-current in rat hippocampal or cortical neurons. It reverses epileptic seizures in rodents. SCR2682 relieves mechanical allodynia and thermal hyperalgesia in rat models of pain.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy
Faseb Journal, 33(8), 9154-9166 (2019)
Activation of Neuronal Voltage-Gated Potassium Kv7/KCNQ/M-Current by a Novel Channel Opener SCR2682 for Alleviation of Chronic Pain
Journal of Pharmacology and Experimental Therapeutics, 377(1), 20-28 (2021)
Attenuation of Epileptogenesis and Cognitive Deficits by a Selective and Potent Kv7 Channel Opener in Rodent Models of Seizures
Journal of Pharmacology and Experimental Therapeutics, 384(2), 315-325 (2023)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service